DEPT OF CLINICAL ONCOLOGY



Researcher : Au GKH

List of Research Outputs

Chan Y.K., Liu W., Long J.R., Yip S.P., Chan S.Y., Shu X.O., Chua D.T.T., Cheung A.N.Y., Ching C.Y.J., Cai H., Au G.K.H., Chan M., Foo W., Ngan H.Y.S., Gao Y.T., Ngan E.S.W., Garcia-Barcelo M.M., Zheng W. and Khoo U.S., Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women., J Med Genet. 2009, 46: 32-39.
Chan Y.K., Liu W., Long J.R., Yip S.P., Chan S.Y., Shu X.O., Chua D.T.T., Cheung A.N.Y., Ching J.C.Y., Cai H., Au G.K.H., Chan M., Foo W., Ngan H.Y.S., Gao Y.T., Ngan E.S.W., Garcia-Barcelo M.M., Zheng W.E.I. and Khoo U.S., Functional polymorphisms in the promoter of BRCA1 influences transcription and are associated with decreased risk for breast cancer in Chinese women, Journal of Medical Genetics. 2009, 46(1): 32-39.
Chua D.T.T., Wei W.I., Wong M.P., Sham J.S.T., Nicholls J.M. and Au G.K.H., Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma, Head & Neck. 2008, 30(7): 863-7.
Lee V.H.F., Kwong D.L.W., Khong P.L., Chua D.T.T., Ng C.Y., Wong K.W., Chan K.S., Leung T.W. and Au G.K.H., Co-registration and Application of Positron Emission Tomography (PET), Computed Tomography (CT) as compared with Magnetic Resonance Imaging (MRI) in Target Localization for Undifferentiated Carcinoma of the Nasopharynx (NPC), Hong Kong International Cancer Congress 2008. Hong Kong, Hong Kong International Cancer Congress.
Tsang J.W.H., Lai T.L., Lau D.H.W., Au G.K.H. and Chua D.T.T., Triple-negative breast cancer in Hong Kong Chinese patients, American Society of Clinical Oncology (ASCO) Annual Meeting. 2009.


Researcher : Bi J

List of Research Outputs

Bi J., Lau B.S.H., Hu L., Rao H.L., Liu B.H., Zhan W.H., Chen G., Wen J.M., Wang Q., Li B. and Guan X.Y., Downregulation of ZIP Kinase is associated with tumor invasion, metastasis and poor prognosis in gastric cancer, International Journal of Cancer. 2009, 124: 1587-1593.
Chow H.Y., Chua D.T.T., Sham J.S.T., Zhang M., Chow L.W.C., Bi J., Ma N.F., Xie D., Loo W.T., Fung J.M.W., Fu L. and Guan X.Y., Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors., Proteomics Clin Appl. 2009, 3: 654-662.


Researcher : Chan HM

List of Research Outputs

Chan H.M., Chen L., Ma S.K.Y., Hu L., Wang J. and Guan X.Y., CHD1L contributes to hepatocarcinogenesis by transcriptionally activating TCTP-mediated mitotic defects and chromosome missegregation, American Association for Cancer Research. 2009.
Chen L., Hu L., Chan H.M. and Guan X.Y., CHD1L suppresses the nucleus-to-mitochondria translocation of Nur77 to sustain hepatocellular carcinoma cell survival, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Chen L., Hu L., Chan H.M., Tsao G.S.W., Huo K.K., Fu L., Ma S.K.Y., Zheng B. and Guan X.Y., Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival., Hepatology. 2009, 50: 122-129.
Ma S.K.Y., Chan Y.P., Woolcock B., Hu L., Wong K.Y., Ling M.T., Bainbridge T., Webber D., Chan H.M., Guan X.Y., Lam W., Vielkind J. and Chan K.W., DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancer, International Journal of Cancer. 2009, 124: 2323-2332.


Researcher : Chen L

List of Research Outputs

Chan H.M., Chen L., Ma S.K.Y., Hu L., Wang J. and Guan X.Y., CHD1L contributes to hepatocarcinogenesis by transcriptionally activating TCTP-mediated mitotic defects and chromosome missegregation, American Association for Cancer Research. 2009.
Chen L., Hu L., Chan H.M. and Guan X.Y., CHD1L suppresses the nucleus-to-mitochondria translocation of Nur77 to sustain hepatocellular carcinoma cell survival, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Chen L., Hu L., Chan H.M., Tsao G.S.W., Huo K.K., Fu L., Ma S.K.Y., Zheng B. and Guan X.Y., Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival., Hepatology. 2009, 50: 122-129.
Zhu C., Qin Y.R., Xie D., Chua D.T.T., Fung J.M.W., Chen L., Fu L., Hu L. and Guan X.Y., Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma., Oncogene. 2009, 28: 2821-2828.


Researcher : Chen L

List of Research Outputs

Chan H.M., Chen L., Ma S.K.Y., Hu L., Wang J. and Guan X.Y., CHD1L contributes to hepatocarcinogenesis by transcriptionally activating TCTP-mediated mitotic defects and chromosome missegregation, American Association for Cancer Research. 2009.
Chen L., Hu L., Chan H.M. and Guan X.Y., CHD1L suppresses the nucleus-to-mitochondria translocation of Nur77 to sustain hepatocellular carcinoma cell survival, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Chen L., Hu L., Chan H.M., Tsao G.S.W., Huo K.K., Fu L., Ma S.K.Y., Zheng B. and Guan X.Y., Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival., Hepatology. 2009, 50: 122-129.
Zhu C., Qin Y.R., Xie D., Chua D.T.T., Fung J.M.W., Chen L., Fu L., Hu L. and Guan X.Y., Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma., Oncogene. 2009, 28: 2821-2828.


Researcher : Cheung AKL

List of Research Outputs

Lung H.L., Lo P.H.Y., Apte S.S., Cheung A.K.L. and Lung M.L., Involvement of a tumor suppressor gene, ADAMTS9, in Nasopharyngeal Carcinoma. , The 4th International Symposium Nasopharyngeal carcinoma. 2009.


Researcher : Chow HY

List of Research Outputs

Chow H.Y., Chua D.T.T., Sham J.S.T., Zhang M., Chow L.W.C., Bi J., Ma N.F., Xie D., Loo W.T., Fung J.M.W., Fu L. and Guan X.Y., Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors., Proteomics Clin Appl. 2009, 3: 654-662.


Researcher : Chua DTT

List of Research Outputs

Chan Y.K., Liu W., Long J.R., Yip S.P., Chan S.Y., Shu X.O., Chua D.T.T., Cheung A.N.Y., Ching C.Y.J., Cai H., Au G.K.H., Chan M., Foo W., Ngan H.Y.S., Gao Y.T., Ngan E.S.W., Garcia-Barcelo M.M., Zheng W. and Khoo U.S., Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women., J Med Genet. 2009, 46: 32-39.
Chan Y.K., Liu W., Long J.R., Yip S.P., Chan S.Y., Shu X.O., Chua D.T.T., Cheung A.N.Y., Ching J.C.Y., Cai H., Au G.K.H., Chan M., Foo W., Ngan H.Y.S., Gao Y.T., Ngan E.S.W., Garcia-Barcelo M.M., Zheng W.E.I. and Khoo U.S., Functional polymorphisms in the promoter of BRCA1 influences transcription and are associated with decreased risk for breast cancer in Chinese women, Journal of Medical Genetics. 2009, 46(1): 32-39.
Chow H.Y., Chua D.T.T., Sham J.S.T., Zhang M., Chow L.W.C., Bi J., Ma N.F., Xie D., Loo W.T., Fung J.M.W., Fu L. and Guan X.Y., Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors., Proteomics Clin Appl. 2009, 3: 654-662.
Chua D.T.T., Wu S.X., Lee V.H.F. and Tsang J.W.H., Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis, Head & Neck Oncology. 2009, 1: 13.
Chua D.T.T., Wei W.I., Wong M.P., Sham J.S.T., Nicholls J.M. and Au G.K.H., Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma, Head & Neck. 2008, 30(7): 863-7.
Chua D.T.T., Hung K.N., Lee V.H.F., Ng C.Y. and Tsang J.W.H., Validation of a prognostic scoring system for locally recurrent nasopharyngeal carcinoma treated by stereotactic radiosurgery, BMC Cancer. 2009, 9: 131.
Lee V.H.F., Kwong D.L.W., Khong P.L., Chua D.T.T., Ng C.Y., Wong K.W., Chan K.S., Leung T.W. and Au G.K.H., Co-registration and Application of Positron Emission Tomography (PET), Computed Tomography (CT) as compared with Magnetic Resonance Imaging (MRI) in Target Localization for Undifferentiated Carcinoma of the Nasopharynx (NPC), Hong Kong International Cancer Congress 2008. Hong Kong, Hong Kong International Cancer Congress.
Leung L.H., Tam I.Y., Tin P.C., Chua D.T.T., Sihoe A.D.L., Cheung L.C., Ho J.C.M., Chung L.P. and Wong M.P., Src Promotes Survival and Invasion of Lung Cancers with Epidermal Growth Factor Receptor Abnormalities and Is a Potential Candidate for Molecular-Targeted Therapy., Molecular Cancer Research. 2009, 7(6): 923-32.
Lung H.L., Lo C.C., Wong C.C., Cheung A.K., Cheong K.F., Wong N., Kwong F.M., Chan K.C., Law E.W., Tsao G.S.W., Chua D.T.T., Sham J.S.T., Cheng Y., Stanbridge E.J., Robertson G.P. and Lung M.L., Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma., International Journal of Cancer. 2008, 122: 1288-1296.
Lung H.L., Chua D.T.T. and Lung M.L., The role of serum amyloid A1 (SAA1) in nasopharyngeal carcinoma, RGC, GRF. 2009.
Tam I.Y., Leung L.H., Tin P.C., Chua D.T.T., Sihoe A.D.L., Cheng L.C., Chung L.P. and Wong M.P., EGFR mutants containing rare EGFR mutant types show reduced response to in-vitro gefitinib compared to common activating missense mutations (Poster), American Association for Cancer Research Annual Meeting, 2009 April 18-22, 2009, Denver, Colorado, the United State . 2009.
Tsang J.W.H., Lai T.L., Lau D.H.W., Au G.K.H. and Chua D.T.T., Triple-negative breast cancer in Hong Kong Chinese patients, American Society of Clinical Oncology (ASCO) Annual Meeting. 2009.
Zhu C., Qin Y.R., Xie D., Chua D.T.T., Fung J.M.W., Chen L., Fu L., Hu L. and Guan X.Y., Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma., Oncogene. 2009, 28: 2821-2828.


Researcher : Dong S

List of Research Outputs

Dong S., Fu L., Lu S. and Guan X.Y., Loss of tyrosine aminotransferase may involved in the pathogenesis of hepatocellular carcinoma, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.


Researcher : Fu L

List of Research Outputs

Chen L., Hu L., Chan H.M., Tsao G.S.W., Huo K.K., Fu L., Ma S.K.Y., Zheng B. and Guan X.Y., Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival., Hepatology. 2009, 50: 122-129.
Chow H.Y., Chua D.T.T., Sham J.S.T., Zhang M., Chow L.W.C., Bi J., Ma N.F., Xie D., Loo W.T., Fung J.M.W., Fu L. and Guan X.Y., Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors., Proteomics Clin Appl. 2009, 3: 654-662.
Dong S., Fu L., Lu S. and Guan X.Y., Loss of tyrosine aminotransferase may involved in the pathogenesis of hepatocellular carcinoma, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Guan X.Y., Zhang C., Fu L., Fu J., Hu L., Li Y., Yang H. and Liu H., FGFR2-positive fibroblasts provide a suitable microenvirenment for tumor development and progression in esophageal carcinoma, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Hu X.T., Zhang F.B., Fan Y.C., Shu X.S., Wong A.H., Zhou W., Shi Q.L., Tang H.M., Fu L., Guan X.Y., Rha S.Y., Tao Q. and He C., Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer., Oncogene. 2009.
Kong K.L., Fu L., Kwong D.L.W. and Guan X.Y., Characterization of a novel tumor suppressor gene UPK1A in esophageal squanous cell carcinoma, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Ma N., Lau B.S.H., Hu L., Xie D., Wu J., Yang J., Wang Y., Wu M.C., Fung J., Bai X., Tzang C.H., Fu L., Yang M., Su Y.A. and Guan X.Y., COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis, Clinical Cancer Research. 2008, 14: 5061-8.
Qin Y., Fu L., Sham P.C., Kwong D.L.W., Zhu C., Chu K.K., Li Y. and Guan X.Y., Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. , Int J Cancer. 2008, 123: 826-30.
Zhang C., Fu L., Fu J., Hu L., Yang H., Rong T.H., Li Y., Liu H., Fu S.B., Zeng Y.X. and Guan X.Y., Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma., Clinical Cancer Research. 2009, 15: 4017-4027.
Zhu C., Qin Y.R., Xie D., Chua D.T.T., Fung J.M.W., Chen L., Fu L., Hu L. and Guan X.Y., Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma., Oncogene. 2009, 28: 2821-2828.


Researcher : Fung JMW

List of Research Outputs

Chow H.Y., Chua D.T.T., Sham J.S.T., Zhang M., Chow L.W.C., Bi J., Ma N.F., Xie D., Loo W.T., Fung J.M.W., Fu L. and Guan X.Y., Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors., Proteomics Clin Appl. 2009, 3: 654-662.
Fung J.M.W., Smith R., Brown M.A., Lau B.S.H., Lau G. and Guan X.Y., Identification and characterization of a novel melanoma tumor suppressor gene on human chromosome 6q21, Clinical Cancer Research. 2009, 15: 797-803.
Zhu C., Qin Y.R., Xie D., Chua D.T.T., Fung J.M.W., Chen L., Fu L., Hu L. and Guan X.Y., Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma., Oncogene. 2009, 28: 2821-2828.


Researcher : Guan XY

List of Research Outputs

Bi J., Lau B.S.H., Hu L., Rao H.L., Liu B.H., Zhan W.H., Chen G., Wen J.M., Wang Q., Li B. and Guan X.Y., Downregulation of ZIP Kinase is associated with tumor invasion, metastasis and poor prognosis in gastric cancer, International Journal of Cancer. 2009, 124: 1587-1593.
Chan H.M., Chen L., Ma S.K.Y., Hu L., Wang J. and Guan X.Y., CHD1L contributes to hepatocarcinogenesis by transcriptionally activating TCTP-mediated mitotic defects and chromosome missegregation, American Association for Cancer Research. 2009.
Chen L., Hu L., Chan H.M. and Guan X.Y., CHD1L suppresses the nucleus-to-mitochondria translocation of Nur77 to sustain hepatocellular carcinoma cell survival, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Chen L., Hu L., Chan H.M., Tsao G.S.W., Huo K.K., Fu L., Ma S.K.Y., Zheng B. and Guan X.Y., Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival., Hepatology. 2009, 50: 122-129.
Chen W., Luo J., Hua W., Zhou F., Lin M.C., Kung H.F., Zeng Y., Guan X.Y. and Xie D., Overexpression of EIF-5A2 is an Independent Predictor of Outcome in Patients of Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy, Cancer Epidemiology, Biomarkers & Prevention. 2009, 18: 400-408.
Cheung A.N.Y., Guan X.Y. and Ngan H.Y.S., Application of novel markers to cervical cytology for enhancing cervical cancer screening, Health Research Symposium 2007: Building bridges between research, practice & policy, Hong Kong, 30 Sep - 1 Oct. 2008.
Chow H.Y., Chua D.T.T., Sham J.S.T., Zhang M., Chow L.W.C., Bi J., Ma N.F., Xie D., Loo W.T., Fung J.M.W., Fu L. and Guan X.Y., Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors., Proteomics Clin Appl. 2009, 3: 654-662.
Deng W., Tsao G.S.W., Kwok K.Y., Wong E.S.Y., Huang X.R., Liu S., Tsang C.M., Ngan H.Y.S., Cheung A.N.Y., Lan H.Y., Guan X.Y. and Cheung A., Transforming growth factor b1 promotes chromosomal instability in human papillomavirus 16 E6E7-infected cervical epithelial cells, Cancer Research. 2008, 68: 7200-7209.
Dong S., Fu L., Lu S. and Guan X.Y., Loss of tyrosine aminotransferase may involved in the pathogenesis of hepatocellular carcinoma, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Fung J.M.W., Smith R., Brown M.A., Lau B.S.H., Lau G. and Guan X.Y., Identification and characterization of a novel melanoma tumor suppressor gene on human chromosome 6q21, Clinical Cancer Research. 2009, 15: 797-803.
Guan X.Y., Zhang C., Fu L., Fu J., Hu L., Li Y., Yang H. and Liu H., FGFR2-positive fibroblasts provide a suitable microenvirenment for tumor development and progression in esophageal carcinoma, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Hu X.T., Zhang F.B., Fan Y.C., Shu X.S., Wong A.H., Zhou W., Shi Q.L., Tang H.M., Fu L., Guan X.Y., Rha S.Y., Tao Q. and He C., Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer., Oncogene. 2009.
Kong K.L., Fu L., Kwong D.L.W. and Guan X.Y., Characterization of a novel tumor suppressor gene UPK1A in esophageal squanous cell carcinoma, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Lu S., Lu L., Guan X.Y. and Huang J., Pdss2 Conditional Knockout Mouse Model, 13th Research Postgraduate Symposium, Hong Kong December 10 & 11. 2008.
Luo J.H., Hua W.F., Rao H.L., Liao Y., Kung H.F., Zeng Y.X., Guan X.Y. and Cehn W., Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder, Cancer Science. 2009, 100: 896-902.
Ma N., Lau B.S.H., Hu L., Xie D., Wu J., Yang J., Wang Y., Wu M.C., Fung J., Bai X., Tzang C.H., Fu L., Yang M., Su Y.A. and Guan X.Y., COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis, Clinical Cancer Research. 2008, 14: 5061-8.
Ma S.K.Y., Chan K.W., Lee K.W., Tang K.H., Wo Y.H., Zheng B. and Guan X.Y., Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations, Molecular Cancer Research. 2008, 6: 1146-1153.
Ma S.K.Y., Chan Y.P., Woolcock B., Hu L., Wong K.Y., Ling M.T., Bainbridge T., Webber D., Chan H.M., Guan X.Y., Lam W., Vielkind J. and Chan K.W., DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancer, International Journal of Cancer. 2009, 124: 2323-2332.
Ma S.K.Y., Chan K.W. and Guan X.Y., In search of liver cancer stem cells, Stem Cell Reviews. 2008, 4: 179-192.
Ma S.K.Y., Chan Y.P., Lee K.W., Tang K.H., Ng I.O.L., Man K., To K.F., Zheng B., Chan K.W. and Guan X.Y., The role of miR-130b in the regulation of CD133+ cancer stem cells-driven hepatocellular carcinoma, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, U.S.A., 18-22 April 2009.
Qin Y., Fu L., Sham P.C., Kwong D.L.W., Zhu C., Chu K.K., Li Y. and Guan X.Y., Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. , Int J Cancer. 2008, 123: 826-30.
Tang K.H., Ma S.K.Y., Lee K.W., Ng I.O.L., Man K., To K.F., Zheng B., Guan X.Y. and Chan K.W., CD133+ liver cancer stem cells promote tumor growth and angiogenesis through increased interleukin-8 secretion, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, U.S.A., 18-22 April 2009.
Yang G.F., Liu J.H., Luo J.H., Li L.J., Hua W.F., Wu H.M., Kung H.F., Zeng Y.X. and Guan X.Y., Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma, Gynecol Oncology. 2009, 112: 314-318.
Zhang C., Fu L., Fu J., Hu L., Yang H., Rong T.H., Li Y., Liu H., Fu S.B., Zeng Y.X. and Guan X.Y., Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma., Clinical Cancer Research. 2009, 15: 4017-4027.
Zhou J., Huang J., Poon V.K.M., Chen D.Q., Chan C.C.S., Ng F., Guan X.Y., Watt R.M., Lu L., Yuen K.Y. and Zheng B., Functional dissection of an IFN-α/β receptor 1 promoter variant that confers higher risk to chronic hepatitis B virus infection , Journal of Hepatology. 2009, V51(2): 322-32.
Zhu C., Qin Y.R., Xie D., Chua D.T.T., Fung J.M.W., Chen L., Fu L., Hu L. and Guan X.Y., Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma., Oncogene. 2009, 28: 2821-2828.


Researcher : Hu L

List of Research Outputs

Bi J., Lau B.S.H., Hu L., Rao H.L., Liu B.H., Zhan W.H., Chen G., Wen J.M., Wang Q., Li B. and Guan X.Y., Downregulation of ZIP Kinase is associated with tumor invasion, metastasis and poor prognosis in gastric cancer, International Journal of Cancer. 2009, 124: 1587-1593.
Chan H.M., Chen L., Ma S.K.Y., Hu L., Wang J. and Guan X.Y., CHD1L contributes to hepatocarcinogenesis by transcriptionally activating TCTP-mediated mitotic defects and chromosome missegregation, American Association for Cancer Research. 2009.
Chen L., Hu L., Chan H.M. and Guan X.Y., CHD1L suppresses the nucleus-to-mitochondria translocation of Nur77 to sustain hepatocellular carcinoma cell survival, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Chen L., Hu L., Chan H.M., Tsao G.S.W., Huo K.K., Fu L., Ma S.K.Y., Zheng B. and Guan X.Y., Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival., Hepatology. 2009, 50: 122-129.
Guan X.Y., Zhang C., Fu L., Fu J., Hu L., Li Y., Yang H. and Liu H., FGFR2-positive fibroblasts provide a suitable microenvirenment for tumor development and progression in esophageal carcinoma, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Ma N., Lau B.S.H., Hu L., Xie D., Wu J., Yang J., Wang Y., Wu M.C., Fung J., Bai X., Tzang C.H., Fu L., Yang M., Su Y.A. and Guan X.Y., COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis, Clinical Cancer Research. 2008, 14: 5061-8.
Ma S.K.Y., Chan Y.P., Woolcock B., Hu L., Wong K.Y., Ling M.T., Bainbridge T., Webber D., Chan H.M., Guan X.Y., Lam W., Vielkind J. and Chan K.W., DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancer, International Journal of Cancer. 2009, 124: 2323-2332.
Zhang C., Fu L., Fu J., Hu L., Yang H., Rong T.H., Li Y., Liu H., Fu S.B., Zeng Y.X. and Guan X.Y., Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma., Clinical Cancer Research. 2009, 15: 4017-4027.
Zhu C., Qin Y.R., Xie D., Chua D.T.T., Fung J.M.W., Chen L., Fu L., Hu L. and Guan X.Y., Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma., Oncogene. 2009, 28: 2821-2828.


Researcher : Kong KL

List of Research Outputs

Kong K.L., Fu L., Kwong D.L.W. and Guan X.Y., Characterization of a novel tumor suppressor gene UPK1A in esophageal squanous cell carcinoma, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.


Researcher : Kwok SL

List of Research Outputs

Kwok S.L., Tsang J.W.H. and Karlberg J.P.E., Current trend of breast cancer therapeutics from the U.S. clinical trial database, ASCO Annual Meeting . 2009.
Kwok S.L., Tsang J.W.H. and Karlberg J.P.E., The changing fashion of breast cancer therapeutics: Analysis of the clinical trial database, St. Gallen Oncology Conference - 11th International Conference: Primary Therapy of Early Breast Cancer - Evidence, Controversies and Consensus . 2009.


Researcher : Kwong DLW

List of Research Outputs

Chan K.S., Mak H.K.F., Ngan S.S.C., Kwong D.L.W. and Khong P.L., Nasopharyngeal carcinoma: relationship between 18F-FDG PET/CT maximum standardized uptake vaule and lesion size with TNM-classification, 15th Hong Kong International Cancer Congress, Hong Kong, 12-14 November 2008.
Chan K.S., Mak H.K.F., Ngan S.S.C., Kwong D.L.W. and Khong P.L., Nasopharyngeal carcinoma: relationship between 18F-FDG PET/CT maximum standardized uptake vaule and lesion size with TNM-classification, 16th Annual Scientific Meeting of Hong Kong College of Radiologists, Hong Kong, 1-2 November 2008.
Choy Y.W.E., Siu K.L., Kok K.H., Lung R.W.M., Tsang C.M., To K.F., Kwong D.L.W., Tsao G.S.W. and Jin D., An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival, Journal of Experimental Medicine. 2008, 205: 2551-2560.
Kong K.L., Fu L., Kwong D.L.W. and Guan X.Y., Characterization of a novel tumor suppressor gene UPK1A in esophageal squanous cell carcinoma, The 100th Annual Meeting of the American Association for Cancer Research, Denver, Colorado, USA, April 18-22, 2009.. 2009.
Kwong D.L.W., A randomized trial comparing intensity modulated radiotherapy versus 2-dimensional radiotherapy for stage II nasopharyngeal carcinoma., American Society for Therapeutic Radiology and Oncology 50th Annual Meeting, Boston, USA. 2008.
Kwong D.L.W., COX-2 inhibition in combination with pre-operative chemoradiation for CA esophagus, The American Society of Clinical Oncology 2009 Annual Meeting, Orlando, Florida, USA. 2009.
Kwong D.L.W., Law S.Y.K., Tong K.H., Wong K.H. and Nicholls J.M., COX-2 inhibition in combination with preoperative chemoradiation for CA esophagus (Abstract), Annual Meeting of the American Society of Clinical Oncology (ASCO), Orlando, USA, 29 May - 2 June. 2009.
Kwong D.L.W., Intensity-modulated radiotherapy for NPC, Hong Kong International Cancer Congress. 2008.
Kwong D.L.W., To treat or not to treat? An oncologist's perspective on suspension of radiation treatment due to patient position deviations, Inauguration Conference of the Hong Kong College of Radiographers and Radiation Therapists. 2008.
Kwong D.L.W., Treatment of rhabdomyosarcoma: chance and challenges, 16th Annual Scientific Meeting of the Hong Kong College of Radiologists. 2008.
Lee V.H.F., Kwong D.L.W., Khong P.L., Chua D.T.T., Ng C.Y., Wong K.W., Chan K.S., Leung T.W. and Au G.K.H., Co-registration and Application of Positron Emission Tomography (PET), Computed Tomography (CT) as compared with Magnetic Resonance Imaging (MRI) in Target Localization for Undifferentiated Carcinoma of the Nasopharynx (NPC), Hong Kong International Cancer Congress 2008. Hong Kong, Hong Kong International Cancer Congress.
Ng C.Y., Lee V.H.F., Kwong D.L.W., Law M.L. and Wu P.M., Comparing the Sensitivity of Ionization Chamber Array to Film + Point Dose Measurement to IMRT Delivery Errors, The American Association of Physicists in Medicine (AAPM). AAPM, 2009.
Nicholls J.M., Chan M.C.W., Chan W.Y., Cheung C.Y., Kwong D.L.W., Wong M.P., Poon L.L.M., Tsao G.S.W. and Guan Y., 2008 Research Output Prize/Faculty Outstanding Research Output Award, The University of Hong Kong. 2008.
Qin Y., Fu L., Sham P.C., Kwong D.L.W., Zhu C., Chu K.K., Li Y. and Guan X.Y., Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. , Int J Cancer. 2008, 123: 826-30.
Schetter A.J., Leung S.Y., Sohn J.J., Zanetti K.A., Bowman E.D., Yanaihara N., Yuen S.T., Chan T.L., Kwong D.L.W., Au G.K., Liu C.G., Calin G.A., Croce C.M. and Harris C.C., MicroRNA Expression Profiles Associated With Prognosis And Therapeutic Outcome In Colon Adenocarcinoma., Journal of the American Medical Association. 2008, 299: 425-36.
Tong K.H., Kwong D.L.W., Law S.Y.K., Wong K.H. and Wong J., Cervical nodal metastasis from intrathoracic esophageal squamous cell carcinoma is not necessarily an incurable disease, Journal of Gastrointestinal Surgery. 2008, 12(10): 1638-1645.
Tsao G.S.W., Tsang C.M., Zhang G., Hau P.M., Man C.W.Y., Yip Y.L., Lee L.S., Seto E., Takada K., Cao Y., Chen H., Lo K.W., Jin D. and Kwong D.L.W., Establishment of stable infection of Epstein-Barr Virus in premalignant nasopharyngeal epithelial cells, Proceedings of EBV Symposium. 2008.
Yuen P.W., Kwong D.L.W., Leung G.K.K., Lee R. and Trendell-Smith N.J., Minimally invasive endoscopic surgery of anterior skull base, Hong Kong Academy of Medicine 15th Anniversary Congress entitled "Working together - the power of collaboration". 2008.


Researcher : Lai TL

List of Research Outputs

Tsang J.W.H., Lai T.L., Lau D.H.W., Au G.K.H. and Chua D.T.T., Triple-negative breast cancer in Hong Kong Chinese patients, American Society of Clinical Oncology (ASCO) Annual Meeting. 2009.


Researcher : Lau BSH

List of Research Outputs

Bi J., Lau B.S.H., Hu L., Rao H.L., Liu B.H., Zhan W.H., Chen G., Wen J.M., Wang Q., Li B. and Guan X.Y., Downregulation of ZIP Kinase is associated with tumor invasion, metastasis and poor prognosis in gastric cancer, International Journal of Cancer. 2009, 124: 1587-1593.
Fung J.M.W., Smith R., Brown M.A., Lau B.S.H., Lau G. and Guan X.Y., Identification and characterization of a novel melanoma tumor suppressor gene on human chromosome 6q21, Clinical Cancer Research. 2009, 15: 797-803.
Ma N., Lau B.S.H., Hu L., Xie D., Wu J., Yang J., Wang Y., Wu M.C., Fung J., Bai X., Tzang C.H., Fu L., Yang M., Su Y.A. and Guan X.Y., COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis, Clinical Cancer Research. 2008, 14: 5061-8.


Researcher : Lee VHF

List of Research Outputs

Chua D.T.T., Wu S.X., Lee V.H.F. and Tsang J.W.H., Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis, Head & Neck Oncology. 2009, 1: 13.
Chua D.T.T., Hung K.N., Lee V.H.F., Ng C.Y. and Tsang J.W.H., Validation of a prognostic scoring system for locally recurrent nasopharyngeal carcinoma treated by stereotactic radiosurgery, BMC Cancer. 2009, 9: 131.
Lee V.H.F., Brain Tumour: Presentation, Investigation and Management for the Elderly., Hong Kong Anti-Cancer Society 2009. Hong Kong, Hong Kong Anti-Cancer Society, 2009.
Lee V.H.F., Brain tumour: presentation, investigation and management, In: Dr. Lee Ho Fun Victor, Hong Kong Anti-Cancer Society. 2008.
Lee V.H.F., Kwong D.L.W., Khong P.L., Chua D.T.T., Ng C.Y., Wong K.W., Chan K.S., Leung T.W. and Au G.K.H., Co-registration and Application of Positron Emission Tomography (PET), Computed Tomography (CT) as compared with Magnetic Resonance Imaging (MRI) in Target Localization for Undifferentiated Carcinoma of the Nasopharynx (NPC), Hong Kong International Cancer Congress 2008. Hong Kong, Hong Kong International Cancer Congress.
Ng C.Y., Lee V.H.F., Kwong D.L.W., Law M.L. and Wu P.M., Comparing the Sensitivity of Ionization Chamber Array to Film + Point Dose Measurement to IMRT Delivery Errors, The American Association of Physicists in Medicine (AAPM). AAPM, 2009.
Ng C.Y. and Lee V.H.F., Feasibility Study of LINAC Based Intensity Modulated Total Marrow Irradiation for Paediatirc Patients, Hong Kong International Cancer Congress 2008. Hong Kong, Hong Kong International Cancer Congress.


Researcher : Leung TW

List of Research Outputs

Lee V.H.F., Kwong D.L.W., Khong P.L., Chua D.T.T., Ng C.Y., Wong K.W., Chan K.S., Leung T.W. and Au G.K.H., Co-registration and Application of Positron Emission Tomography (PET), Computed Tomography (CT) as compared with Magnetic Resonance Imaging (MRI) in Target Localization for Undifferentiated Carcinoma of the Nasopharynx (NPC), Hong Kong International Cancer Congress 2008. Hong Kong, Hong Kong International Cancer Congress.


Researcher : Liu KY

List of Research Outputs

Ho A.H.Y., Yuen M.Y., Chan C.L.W., Lam S.F., Chow A.Y.M. and Liu K.Y., Motivation Styles and its Effects on the Subjective Well-being & Coping Efficacy of People with Terminal-Illness., International Conference on Social Work and Counseling Practice.. Hong Kong, 2009.


Researcher : Lo PHY

List of Research Outputs

Lung H.L., Lo P.H.Y., Apte S.S., Cheung A.K.L. and Lung M.L., Involvement of a tumor suppressor gene, ADAMTS9, in Nasopharyngeal Carcinoma. , The 4th International Symposium Nasopharyngeal carcinoma. 2009.


Researcher : Lung HL

List of Research Outputs

Lung H.L., 4th International Symposium on Nasopharyngeal Carcinoma Involvement of a tumor suppressor gene, ADAMTS9, in nasopharyngeal carcinoma, URC/CRCG - Conference Grants for Teaching Staff, HKU. 2009.
Lung H.L., Lo P.H.Y., Apte S.S., Cheung A.K.L. and Lung M.L., Involvement of a tumor suppressor gene, ADAMTS9, in Nasopharyngeal Carcinoma. , The 4th International Symposium Nasopharyngeal carcinoma. 2009.
Lung H.L., Chua D.T.T. and Lung M.L., The role of serum amyloid A1 (SAA1) in nasopharyngeal carcinoma, RGC, GRF. 2009.


Researcher : Lung ML

List of Research Outputs

Chan P.S., Koon H.K., Wu Z.G., Wong R.N., Lung M.L., Chang C.K. and Mak N.K., Role of p38 MAPKs in hypericin photodynamic therapy-induced apoptosis of NPC cells, Photochem Photobio. 2009, epublication.
Lung H.L., Lo P.H.Y., Apte S.S., Cheung A.K.L. and Lung M.L., Involvement of a tumor suppressor gene, ADAMTS9, in Nasopharyngeal Carcinoma. , The 4th International Symposium Nasopharyngeal carcinoma. 2009.
Lung H.L., Chua D.T.T. and Lung M.L., The role of serum amyloid A1 (SAA1) in nasopharyngeal carcinoma, RGC, GRF. 2009.


Researcher : Ma N

List of Research Outputs

Ma N., Lau B.S.H., Hu L., Xie D., Wu J., Yang J., Wang Y., Wu M.C., Fung J., Bai X., Tzang C.H., Fu L., Yang M., Su Y.A. and Guan X.Y., COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis, Clinical Cancer Research. 2008, 14: 5061-8.


Researcher : Ng CY

List of Research Outputs

Chua D.T.T., Hung K.N., Lee V.H.F., Ng C.Y. and Tsang J.W.H., Validation of a prognostic scoring system for locally recurrent nasopharyngeal carcinoma treated by stereotactic radiosurgery, BMC Cancer. 2009, 9: 131.
Lee V.H.F., Kwong D.L.W., Khong P.L., Chua D.T.T., Ng C.Y., Wong K.W., Chan K.S., Leung T.W. and Au G.K.H., Co-registration and Application of Positron Emission Tomography (PET), Computed Tomography (CT) as compared with Magnetic Resonance Imaging (MRI) in Target Localization for Undifferentiated Carcinoma of the Nasopharynx (NPC), Hong Kong International Cancer Congress 2008. Hong Kong, Hong Kong International Cancer Congress.
Ng C.Y. and Lee V.H.F., Feasibility Study of LINAC Based Intensity Modulated Total Marrow Irradiation for Paediatirc Patients, Hong Kong International Cancer Congress 2008. Hong Kong, Hong Kong International Cancer Congress.


Researcher : Qin Y

List of Research Outputs

Qin Y., Fu L., Sham P.C., Kwong D.L.W., Zhu C., Chu K.K., Li Y. and Guan X.Y., Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. , Int J Cancer. 2008, 123: 826-30.


Researcher : Sham JST

List of Research Outputs

Chow H.Y., Chua D.T.T., Sham J.S.T., Zhang M., Chow L.W.C., Bi J., Ma N.F., Xie D., Loo W.T., Fung J.M.W., Fu L. and Guan X.Y., Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors., Proteomics Clin Appl. 2009, 3: 654-662.
Chua D.T.T., Wei W.I., Wong M.P., Sham J.S.T., Nicholls J.M. and Au G.K.H., Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma, Head & Neck. 2008, 30(7): 863-7.
Lung H.L., Lo C.C., Wong C.C., Cheung A.K., Cheong K.F., Wong N., Kwong F.M., Chan K.C., Law E.W., Tsao G.S.W., Chua D.T.T., Sham J.S.T., Cheng Y., Stanbridge E.J., Robertson G.P. and Lung M.L., Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma., International Journal of Cancer. 2008, 122: 1288-1296.


Researcher : Tsang JWH

List of Research Outputs

Chua D.T.T., Wu S.X., Lee V.H.F. and Tsang J.W.H., Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis, Head & Neck Oncology. 2009, 1: 13.
Chua D.T.T., Hung K.N., Lee V.H.F., Ng C.Y. and Tsang J.W.H., Validation of a prognostic scoring system for locally recurrent nasopharyngeal carcinoma treated by stereotactic radiosurgery, BMC Cancer. 2009, 9: 131.
Kwok S.L., Tsang J.W.H. and Karlberg J.P.E., Current trend of breast cancer therapeutics from the U.S. clinical trial database, ASCO Annual Meeting . 2009.
Kwok S.L., Tsang J.W.H. and Karlberg J.P.E., The changing fashion of breast cancer therapeutics: Analysis of the clinical trial database, St. Gallen Oncology Conference - 11th International Conference: Primary Therapy of Early Breast Cancer - Evidence, Controversies and Consensus . 2009.
Tsang J.W.H., Advances of Chemotherapy and Molecular Targeted Therapy, Phone Interview from AM 730 Daily. 2009.
Tsang J.W.H., Anti-cancer Agents, HKU SPACE: Advanced Certificate Course in Pharmacology & Pharmaceutical Management. 2008.
Tsang J.W.H., Breakthroughs in Breast Cancer, The Federation of Medical Societies of Hong Kong Annual Scientific Meeting - Cure in Cancer 2008. 2008.
Tsang J.W.H., Improving Efficacy of Breast Cancer Treatment, Oriental Daily. Hong Kong, 2009.
Tsang J.W.H., New Paradigm in Cancer Treatment - Update on Chemotherapy, Targeted Therapy and Their Side-Effects, Organized by the St. James' Settlement. 2009.
Tsang J.W.H., Overview Of Targeted Therapies And New Targets, Hong Kong College of Radiology Clinical Oncology Intermediate Training Course 2009. 2009.
Tsang J.W.H., Chiang C., Chan K.S., Lau L.S., Mok W., Tse H.Y., Tsui W., Wong B., Yam L. and Yu C., Part-time training and employment: views of Hong Kong frontline doctors, Medical Women's International Association Western Pacific Regional Congress, Melbourne, Australia. 2008.
Tsang J.W.H., Chan A.C.Y., Leung L.W.S., Lo C.S.Y., Fung L.H.K. and Kwong A., Predictive value of 18F-FDG PET-CT in primary breast cancer patients receiving neoadjuvant chemotherapy: the HKU experience, 15th Hong Kong International Cancer Congress 5th Annual Meeting of Centre for Cancer Research Oral Presentation in Biomedicine Young Investigator Award (YIA) Session. 2008.
Tsang J.W.H., Yeung D.W.C., Chan A.C.Y., Wong H.N., Leung L.W.S., Lo C.S.Y., Fung L.H.K., Epstein R. and Kwong A., Predictive value of 18F-FDG PET-CT in primary breast cancer patients receiving neoadjvuant chemotherapy, St. Gallen Oncology Conference - 11th International Conference: Primary Therapy of Early Breast Cancer - Evidence, Controversies and Consensus. 2009.
Tsang J.W.H., Recent Medical Advances in Breast Cancer, The Hong Kong Medical Diary. Hong Kong SAR, 2008, 13: 21-24.
Tsang J.W.H., The Cutting Edge of Breast Cancer Medical Treatment, Health Information, Metro Daily. Hong Kong, 2009.
Tsang J.W.H., Lai T.L., Lau D.H.W., Au G.K.H. and Chua D.T.T., Triple-negative breast cancer in Hong Kong Chinese patients, American Society of Clinical Oncology (ASCO) Annual Meeting. 2009.
Tsang J.W.H., Update on Recent Advances In Breast Cancer Management, Public Health Talk Organized by the Health Action. 2009.
Tsang J.W.H., Update on Triple Negative Breast Cancer, The Hong Kong Anti-Cancer Society Symposium for Medical & Health Professionals: HER2 Status & Treatment of Breast Cancer. 2009.
Tsang J.W.H., Who Needs Adjuvant Therapy? Implication of Pathology Report, New Trends in Breast Cancer - Management Symposium 2009 Organized by the Division of Breast Surgery, Department of Surgery, Tung Wah Hospital & Queen Mary Hospital, University of Hong Kong Medical Center. 2009.


Researcher : Wang J

List of Research Outputs

Chan H.M., Chen L., Ma S.K.Y., Hu L., Wang J. and Guan X.Y., CHD1L contributes to hepatocarcinogenesis by transcriptionally activating TCTP-mediated mitotic defects and chromosome missegregation, American Association for Cancer Research. 2009.


Researcher : Wong KW

List of Research Outputs

Lee V.H.F., Kwong D.L.W., Khong P.L., Chua D.T.T., Ng C.Y., Wong K.W., Chan K.S., Leung T.W. and Au G.K.H., Co-registration and Application of Positron Emission Tomography (PET), Computed Tomography (CT) as compared with Magnetic Resonance Imaging (MRI) in Target Localization for Undifferentiated Carcinoma of the Nasopharynx (NPC), Hong Kong International Cancer Congress 2008. Hong Kong, Hong Kong International Cancer Congress.


Researcher : Xie D

List of Research Outputs

Ma N., Lau B.S.H., Hu L., Xie D., Wu J., Yang J., Wang Y., Wu M.C., Fung J., Bai X., Tzang C.H., Fu L., Yang M., Su Y.A. and Guan X.Y., COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis, Clinical Cancer Research. 2008, 14: 5061-8.


Researcher : Zhu C

List of Research Outputs

Qin Y., Fu L., Sham P.C., Kwong D.L.W., Zhu C., Chu K.K., Li Y. and Guan X.Y., Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. , Int J Cancer. 2008, 123: 826-30.
Zhu C., Qin Y.R., Xie D., Chua D.T.T., Fung J.M.W., Chen L., Fu L., Hu L. and Guan X.Y., Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma., Oncogene. 2009, 28: 2821-2828.


Researcher : Zhu C

List of Research Outputs

Qin Y., Fu L., Sham P.C., Kwong D.L.W., Zhu C., Chu K.K., Li Y. and Guan X.Y., Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. , Int J Cancer. 2008, 123: 826-30.
Zhu C., Qin Y.R., Xie D., Chua D.T.T., Fung J.M.W., Chen L., Fu L., Hu L. and Guan X.Y., Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma., Oncogene. 2009, 28: 2821-2828.


-- End of Listing --